Literature DB >> 17356124

Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome.

Kenzo Kosaka1, Hiroshi Fujiwara, Shinya Yoshioka, Shingo Fujii.   

Abstract

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic disease manifesting itself by ovarian enlargement and massive ascites with increased peritoneal capillary permeability. Although vascular endothelial growth factor (VEGF) is considered to play the main role in developing OHSS, its precise mechanism remains unclear. In this study, we examined possible roles of circulating immune cells in the pathogenesis of OHSS.
METHODS: Peripheral blood mononuclear cells (PBMC) and plasma were collected from healthy non-pregnant volunteers and from patients receiving ovulation induction for IVF. PBMC were cultured for 48 h. Plasma and/or medium concentrations of VEGF, estradiol and progesterone were measured using enzyme-linked immunosorbent assay and radioimmunoassay kits.
RESULTS: VEGF production by cultured PBMC and plasma concentrations of VEGF taken from patients with early onset OHSS (n = 12) were significantly higher than those in non-pregnant volunteers and patients without OHSS whose oocyte retrieval rates were similar to that of OHSS patients. OHSS patients were further classified into a high plasma VEGF concentration group and a high culture medium VEGF group. There was no significant correlation among VEGF production by PBMC and plasma concentration of VEGF, estradiol or progesterone.
CONCLUSION: Although mechanistic evidence has not been provided, our study does provide new evidence to suggest that circulating immune cells are involved in the pathogenesis of OHSS via VEGF production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356124     DOI: 10.1093/humrep/dem042

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Rare genetic variants suggest dysregulation of signaling pathways in low- and high-risk patients developing severe ovarian hyperstimulation syndrome.

Authors:  L Borgwardt; K W Olsen; M Rossing; R Borup Helweg-Larsen; M Toftager; A Pinborg; J Bogstad; K Løssl; A Zedeler; M L Grøndahl
Journal:  J Assist Reprod Genet       Date:  2020-09-18       Impact factor: 3.412

2.  Risk of Higher Blood Pressure in 3 to 6 Years Old Singleton Born From OHSS Patients Undergone With Fresh IVF/ICSI.

Authors:  Yimin Zhu; Yanling Fu; Minyue Tang; Huanmiao Yan; Fanghong Zhang; Xiaoling Hu; Guofang Feng; Yu Sun; Lanfeng Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

3.  Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro.

Authors:  Divya K Shah; K M J Menon; Lourdes M Cabrera; Anjel Vahratian; Shahryar K Kavoussi; Dan I Lebovic
Journal:  Fertil Steril       Date:  2009-04-01       Impact factor: 7.329

4.  Follicle curetting at the time of oocyte retrieval increases the oocyte yield.

Authors:  Stephanie K Dahl; Sara Cannon; Mira Aubuchon; Daniel B Williams; Jared C Robins; Michael A Thomas
Journal:  J Assist Reprod Genet       Date:  2009-06-23       Impact factor: 3.412

5.  Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome: A controlled clinical study.

Authors:  Ya-Qin Wang; Nan Yu; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jing Yang
Journal:  Exp Ther Med       Date:  2014-10-06       Impact factor: 2.447

Review 6.  Dual role for the unfolded protein response in the ovary: adaption and apoptosis.

Authors:  Ning Huang; Yang Yu; Jie Qiao
Journal:  Protein Cell       Date:  2016-09-08       Impact factor: 14.870

7.  Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome.

Authors:  Shohreh Movahedi; Leili Safdarian; Marzieh Agahoseini; Ashraf Aleyasin; Sepideh Khodaverdi; Sara Asadollah; Ali Kord Valeshabad; Parvin Fallahi; Zahra Rezaeeian
Journal:  Med J Islam Repub Iran       Date:  2016-05-17

8.  Tie1 contributes to the development of ovarian hyperstimulation syndrome under the regulation of EGR1 in granulosa cells.

Authors:  Lihua Sun; Hui Tian; Songguo Xue; Hongjuan Ye; Xue Xue; Rongxiang Wang; Yu Liu; Caixia Zhang; Qiuju Chen; Shaorong Gao
Journal:  Exp Mol Med       Date:  2022-01-25       Impact factor: 12.153

9.  GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial.

Authors:  Usama M Fouda; Ahmed M Sayed; Hesham S Elshaer; Bahaa Eldin M Hammad; Mona M Shaban; Khaled A Elsetohy; Mohamed A Youssef
Journal:  J Ovarian Res       Date:  2016-05-17       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.